Analysis of the pharmaceuticals in dosage market size in Italy shows varied trends over the past years. From 2013, the market experienced a decline from 85.427 billion USD to 72.307 billion USD in 2015, followed by a gradual recovery peaking at 92.822 billion USD in 2020. Subsequent years saw a slight decrease, moderating around the 90 billion USD mark in recent years. In 2023, the market stood at 90.42 billion USD. The year-on-year variation noted a 0.45% decline over the last two years. Over the last five years, the average annual growth rate (CAGR) was 3.03% from 2018 to 2023, but a future forecast indicates a decline at a CAGR of -0.35%, with a 1.74% cumulative reduction in value projected by 2028.
Future trends to watch for in the Italian pharmaceuticals market include advancements in biotechnology, shifts towards personalized medicine, the impact of regulatory changes, and the integration of digital health solutions. Additionally, potential economic fluctuations and evolving healthcare policies will influence market dynamics.
